SAEYY OTC
Redcare Pharmacy N.V.
1W: +18.8%
1M: +12.9%
3M: +8.6%
YTD: +5.5%
1Y: -4.7%
3Y: -20.2%
5Y: -59.2%
$8.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$22M
-0.2% ▼
5Y CAGR: +4.4%
Capital Expenditures
$76M
-771.1% ▼
5Y CAGR: +7.4%
Free Cash Flow
-$54M
-504.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$151M
+0.0% ▲
Net Change in Cash
$7M
-45.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$66M | -$69M | -$12M | -$45M | -$36M |
| Depreciation & Amort. | $27M | $40M | $57M | $68M | $67M |
| Stock-Based Comp. | $21M | $16M | $9M | $3M | $0 |
| Change in Working Capital | $29M | -$17M | $13M | -$35M | -$19M |
| Other Non-Cash Items | $1M | $1M | $97M | $31M | $11M |
| Operating Cash Flow | $12M | -$29M | $61M | $22M | $22M |
| — Investing Activities — | |||||
| Capital Expenditures | -$43M | -$54M | -$6M | -$9M | -$114M |
| Acquisitions (Net) | -$31M | -$6M | -$23M | $256K | $0 |
| Investment Purchases | -$29M | -$80M | -$41M | $0 | -$32M |
| Investment Sales | $2M | -$39M | $34M | $0 | $0 |
| Other Investing | $17M | $41M | -$23M | $17M | $0 |
| Investing Cash Flow | -$84M | -$138M | -$60M | $8M | -$145M |
| — Financing Activities — | |||||
| Net Debt Issuance | $230M | -$2M | -$2M | -$13M | -$1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$151M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$12M | -$13M | -$15M | -$9M | -$13M |
| Financing Cash Flow | $230M | -$14M | $15M | -$18M | $119M |
| Net Change in Cash | $157M | -$181M | $17M | $13M | $7M |
| Cash End of Period | $247M | $67M | $84M | $97M | $92M |
| Free Cash Flow | -$32M | -$83M | $23M | $13M | -$54M |